GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » Cash Received from Insurance Activities

Lionco Pharmaceutical Group Co (SHSE:603669) Cash Received from Insurance Activities


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Lionco Pharmaceutical Group Co (SHSE:603669) Business Description

Traded in Other Exchanges
N/A
Address
68 Zetang Nedong commercial building, 2nd Floor, Shannan Prefecture, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.